Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study.
Chen WC, Ngan HY, Yang LY, Chang WY, Wu RC, Chen CY, Lin H, Cheng YM, Kan YY, Tseng CJ, Chang CC, Jung SM, Tung HJ, Tang YH, Lin CT, Chao A, Lai CH.
Chen WC, et al.
Taiwan J Obstet Gynecol. 2022 May;61(3):494-500. doi: 10.1016/j.tjog.2022.03.036.
Taiwan J Obstet Gynecol. 2022.
PMID: 35595444
Free article.
Stage I patients with primary surgery had better 5-year PFS (82.8% vs 50.0% p = 0.020) and OS (89.3% vs 57.1%, p = 0.017) than those with non-primary surgery, while the propensity scores distribution were similar among the treatment groups. CONCLUSION: This study confirmed …
Stage I patients with primary surgery had better 5-year PFS (82.8% vs 50.0% p = 0.020) and OS (89.3% vs 57.1%, p = 0.017) than those with no …